Literature DB >> 18487362

Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis.

Yan Ke1, Guomin Jiang, Deming Sun, Henry J Kaplan, Hui Shao.   

Abstract

PURPOSE: To determine whether CD4(+)CD25(+) T-regulatory cells (Tregs) from the eyes of rats with recurrent (r) experimental autoimmune uveitis (EAU) were less efficient in suppressing intraocular inflammation than those from rats with monophasic (m) disease (m-EAU).
METHODS: m-EAU and r-EAU were induced in Lewis rats by immunization with R16 or by adoptive transfer of R16-specific T cells, respectively. Ocular CD4(+)CD25(+) Tregs were separated from CD4(+) CD25(-) T-effector cells, and the inhibitory functions of Tregs were determined. Aqueous humor (AqH) from m-EAU and r-EAU was collected and studied for its ability to enhance ocular Treg function.
RESULTS: The authors found that the number of ocular CD4(+)CD25(+) (Tregs) increased in the eye during resolution of the first acute attack of intraocular inflammation in m-EAU and r-EAU. However, the suppressor function of these cells was weaker in r-EAU. The suppressor function of ocular Tregs in r-EAU was enhanced by incubation with AqH from animals recovering from m-EAU. Moreover, the weaker suppressor function of ocular Tregs in r-EAU correlated with low or undetectable levels of IL-10 in the AqH and was reversed by the addition of IL-10 to the AqH. Finally, the transfer of ocular Tregs from animals with m-EAU converted r-EAU to a monophasic disease.
CONCLUSIONS: This study demonstrated that although a number of mechanisms may contribute to the recurrence of intraocular inflammation, dysregulation and malfunction of Tregs in the eye are important factors in disease recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487362      PMCID: PMC2567874          DOI: 10.1167/iovs.07-1468

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  52 in total

1.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

2.  Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals.

Authors:  E Allison Green; Yongwon Choi; Richard A Flavell
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

3.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

4.  Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis.

Authors:  K Ohta; B Wiggert; S Yamagami; A W Taylor; J W Streilein
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 6.  Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Authors:  Shimon Sakaguchi; Masahiro Ono; Ruka Setoguchi; Haruhiko Yagi; Shohei Hori; Zoltan Fehervari; Jun Shimizu; Takeshi Takahashi; Takashi Nomura
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 8.  Type 1 T regulatory cells.

Authors:  M G Roncarolo; R Bacchetta; C Bordignon; S Narula; M K Levings
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

9.  Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells.

Authors:  Sayuri Yamazaki; Tomonori Iyoda; Kristin Tarbell; Kara Olson; Klara Velinzon; Kayo Inaba; Ralph M Steinman
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

10.  Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.

Authors:  Lucy S K Walker; Anna Chodos; Mark Eggena; Hans Dooms; Abul K Abbas
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  16 in total

1.  The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis.

Authors:  G Li; L Yuan; X Ren; H Nian; L Zhang; Z C Han; X Li; X Zhang
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

2.  Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats.

Authors:  Lingjun Zhang; Hui Zheng; Hui Shao; Hong Nian; Yan Zhang; Lingling Bai; Chang Su; Xun Liu; Lijie Dong; Xiaorong Li; Xiaomin Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

3.  Tregs in Autoimmune Uveitis.

Authors:  Zhaohao Huang; Wenli Li; Wenru Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  Association Between Noninfectious Uveitis and Psychological Stress.

Authors:  Elyse J Berlinberg; John A Gonzales; Thuy Doan; Nisha R Acharya
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

Review 6.  TIGIT as a Promising Therapeutic Target in Autoimmune Diseases.

Authors:  Chenran Yue; Sheng Gao; Shuting Li; Zhouhang Xing; Hengrong Qian; Ying Hu; Wenqian Wang; Chunyan Hua
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 7.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

8.  Rapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1/Th2/Th17 cells and upregulating CD4+CD25+ Foxp3 regulatory T cells.

Authors:  Li-Fei Yuan; Guang-Da Li; Xin-Jun Ren; Hong Nian; Xiao-Rong Li; Xiao-Min Zhang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

9.  Grouping annotations on the subcellular layered interactome demonstrates enhanced autophagy activity in a recurrent experimental autoimmune uveitis T cell line.

Authors:  Xiuzhi Jia; Jingbo Li; Dejing Shi; Yu Zhao; Yucui Dong; Huanyu Ju; Jinfeng Yang; Jianhua Sun; Xia Li; Huan Ren
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

10.  Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.

Authors:  Ulrike Kaufmann; Maria Diedrichs-Möhring; Gerhild Wildner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.